{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:03:43Z","timestamp":1784293423066,"version":"3.55.0"},"reference-count":34,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shionogi & Co., Ltd.","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Opioid-induced nausea and vomiting (OINV) in patients with cancer imposes a substantial clinical burden and may compromise adherence to opioid therapy. Naldemedine, a peripheral \u03bc-opioid receptor antagonist, is currently approved for the treatment of opioid-induced constipation. Recent evidence suggests similar benefits for the treatment of OINV. This study aims to evaluate the preventive effect of naldemedine on OINV in patients with cancer pain initiating opioid analgesics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This multicentre, double-blind, randomised, placebo-controlled, parallel-group comparison trial will be conducted across 20 hospitals and clinics in Japan. An estimated 120 patients with cancer scheduled to initiate opioid analgesic therapy will be recruited and randomly assigned (1:1) to receive either naldemedine or placebo on day 1 (visit 1). From days 1 to 7, patients will receive blinded study medication concurrently with opioid analgesics and will be followed for 8\u2009days. The primary endpoint will be the proportion of patients achieving a complete response (CR) on day 5, defined as no vomiting and no use of rescue antiemetics for up to 120 hours after initiation of opioid analgesics. Key secondary endpoints will include the proportion of patients achieving CR on days 1, 2, 3 and 7; changes in Numerical Rating Scale scores from baseline; duration of nausea; proportion of patients who experience vomiting; proportion of patients using rescue antiemetics and frequency of rescue antiemetic use. Additionally, the incidence of adverse events and serious adverse events will be recorded throughout the observation period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study has been reviewed and approved by the Hattori Clinic Certified Review Board (approval number: CRB3180027). Written informed consent will be obtained from all participating patients before study commencement. The results of the study will be presented at academic conferences in Japan or overseas and submitted for publication in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT07038551\">NCT07038551<\/jats:ext-link>\n                      and jRCTs031250128.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114092","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:20:13Z","timestamp":1784290813000},"page":"e114092","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Multicentre, double-blind, randomised, placebo-controlled study on the prophylactic use of naldemedine for opioid-induced nausea and vomiting in patients with cancer (POSEIDON study): a protocol paper"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07038551","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yo","family":"Ishihara","sequence":"first","affiliation":[{"name":"Department of Palliative Medicine, International University of Health and Welfare Narita Hospital, Chiba, Japan"},{"name":"Department of Gastroenterology, International University Health and Welfare School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Nursing, International University of Health and Welfare Narita Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuki","family":"Hokabe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, International University of Health and Welfare Narita Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaaki","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, International University of Health and Welfare Narita Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Iwashita","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, International University of Health and Welfare Narita Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, International University of Health and Welfare Narita Hospital, Chiba, Japan"},{"name":"Department of Gastroenterology, International University Health and Welfare School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, International University of Health and Welfare Narita Hospital, Chiba, Japan"},{"name":"Department of Gastroenterology, International University Health and Welfare School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-8815","authenticated-orcid":false,"given":"Yu","family":"Uneno","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Kurihashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kanagawa Dental University Yokohama Clinic, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Satomi","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-9881","authenticated-orcid":false,"given":"Jun","family":"Hamano","sequence":"additional","affiliation":[{"name":"Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Higashibata","sequence":"additional","affiliation":[{"name":"Department of Palliative and Supportive Care, Institute of Medicine, University of Tsukuba, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kosugi","sequence":"additional","affiliation":[{"name":"Department of Palliative and Supportive Care, University of Tsukuba Hospital, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, St. Marianna University School of Medicine, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kajiura","sequence":"additional","affiliation":[{"name":"Medical Oncology and Palliative Medicine Department, Toyama University Hospital, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kida","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Showa University Koto Toyosu Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7257-7429","authenticated-orcid":false,"given":"Tatsuya","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Koretaka","sequence":"additional","affiliation":[{"name":"Data Science Department, Shionogi & Co., Ltd, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhiro","family":"Sonoyama","sequence":"additional","affiliation":[{"name":"Drug Development and Regulatory Science Division, Shionogi & Co., Ltd, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Oyamada","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, JORTC Data Centre, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-1436","authenticated-orcid":false,"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-1386","authenticated-orcid":false,"given":"Takaomi","family":"Kessoku","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, International University of Health and Welfare Narita Hospital, Chiba, Japan"},{"name":"Department of Gastroenterology, International University Health and Welfare School of Medicine, Chiba, Japan"},{"name":"Department of Internal Medicine, Kanagawa Dental University Yokohama Clinic, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2026071705200725000_16.7.e114092.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18472"},{"key":"2026071705200725000_16.7.e114092.2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy152"},{"key":"2026071705200725000_16.7.e114092.3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/JPR.S97759","article-title":"Effectiveness of the World Health Organization cancer pain relief guidelines: An integrative review","volume":"9","author":"Carlson","year":"2016","journal-title":"J Pain Res"},{"key":"2026071705200725000_16.7.e114092.4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5056\/jnm23144","article-title":"Opioid-induced constipation: Old and new concepts in diagnosis and treatment","volume":"30","author":"Squeo","year":"2024","journal-title":"J Neurogastroenterol Motil"},{"key":"2026071705200725000_16.7.e114092.5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/ph14111091","article-title":"Opioid analgesia and opioid-induced adverse effects: A review","volume":"14","author":"Paul","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026071705200725000_16.7.e114092.6","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.851082"},{"key":"2026071705200725000_16.7.e114092.7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40122-022-00354-4","article-title":"Opioid-induced constipation in real-world practice: A physician survey, 1 year later","volume":"11","author":"Alvaro","year":"2022","journal-title":"Pain Ther"},{"key":"2026071705200725000_16.7.e114092.8","article-title":"Incidence and health related quality of life of opioid-induced constipation in chronic noncancer pain patients: A prospective multicentre cohort study","volume":"2018","author":"Veiga","year":"2018","journal-title":"Pain Res Treat"},{"key":"2026071705200725000_16.7.e114092.9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115797","article-title":"Mechanisms of nausea and vomiting: Current knowledge and recent advances in intracellular emetic signaling systems","volume":"22","author":"Zhong","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026071705200725000_16.7.e114092.10","first-page":"121","article-title":"Opioid-induced nausea and vomiting","volume":"1","author":"Smith","year":"2012","journal-title":"Ann Palliat Med"},{"key":"2026071705200725000_16.7.e114092.11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/jpm.2023.0314","article-title":"Analysis of nausea and vomiting frequency following opioid dose escalation and its risk factors: A single-center retrospective observational study","volume":"27","author":"Yamamoto","year":"2024","journal-title":"J Palliat Med"},{"key":"2026071705200725000_16.7.e114092.12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00325481.2017.1243004","article-title":"Economic and clinical burden of opioid-induced nausea and vomiting","volume":"129","author":"Nicholson","year":"2017","journal-title":"Postgrad Med"},{"key":"2026071705200725000_16.7.e114092.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-009-0775-3"},{"key":"2026071705200725000_16.7.e114092.14","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318237d626"},{"key":"2026071705200725000_16.7.e114092.15","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2013.0613"},{"key":"2026071705200725000_16.7.e114092.16","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2015.0203"},{"key":"2026071705200725000_16.7.e114092.17","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0225"},{"key":"2026071705200725000_16.7.e114092.18","first-page":"270","article-title":"The efficacy of prophylactic prochlorperazine injections at the initiation of opioid injections in preventing opioid-induced nausea and vomiting among patients with end-stage cancer","volume":"9","author":"Imai","year":"2023","journal-title":"Fujita Med J"},{"key":"2026071705200725000_16.7.e114092.19","unstructured":"EU_Naldemedine. EU_N , Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rizmoic"},{"key":"2026071705200725000_16.7.e114092.20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-017-0750-0","article-title":"Naldemedine: First global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"2026071705200725000_16.7.e114092.21","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2147\/JPR.S282738","article-title":"Naldemedine improves patient-reported outcomes of opioid-induced constipation in patients with chronic non-cancer pain in the COMPOSE phase 3 studies","volume":"14","author":"Camilleri","year":"2021","journal-title":"J Pain Res"},{"key":"2026071705200725000_16.7.e114092.22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2468-1253(17)30105-X","article-title":"Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): Two multicentre, phase 3, double-blind, randomised, parallel-group trials","volume":"2","author":"Hale","year":"2017","journal-title":"The Lancet Gastroenterol Hepatol"},{"key":"2026071705200725000_16.7.e114092.23","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2017.73.0853","article-title":"Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer","volume":"35","author":"Katakami","year":"2017","journal-title":"J Clin Oncol"},{"key":"2026071705200725000_16.7.e114092.24","doi-asserted-by":"crossref","first-page":"118048","DOI":"10.1016\/j.lfs.2020.118048","article-title":"Preventive effects of naldemedine, peripherally acting \u03bc-opioid receptor antagonist, on morphine-induced nausea and vomiting in ferrets","volume":"257","author":"Kanemasa","year":"2020","journal-title":"Life Sci"},{"key":"2026071705200725000_16.7.e114092.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00381"},{"key":"2026071705200725000_16.7.e114092.26","unstructured":"JCOG. 2025. Available: https:\/\/jcog.jp\/doctor\/tool\/ctcaev5"},{"key":"2026071705200725000_16.7.e114092.27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1272\/jnms.82.100","article-title":"Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients","volume":"82","author":"Yamada","year":"2015","journal-title":"J Nippon Med Sch"},{"key":"2026071705200725000_16.7.e114092.28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15360288.2020.1829250","article-title":"Predictive factors of opioid-induced nausea in cancer patients","volume":"35","author":"Ogawa","year":"2021","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2026071705200725000_16.7.e114092.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.04.014"},{"key":"2026071705200725000_16.7.e114092.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00349-9"},{"key":"2026071705200725000_16.7.e114092.31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/147323001103900106","article-title":"The Bowel Function Index for evaluating constipation in pain patients: Definition of a reference range for a non-constipated population of pain patients","volume":"39","author":"Ueberall","year":"2011","journal-title":"J Int Med Res"},{"key":"2026071705200725000_16.7.e114092.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.06.022"},{"key":"2026071705200725000_16.7.e114092.33","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9939-y"},{"key":"2026071705200725000_16.7.e114092.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.05.009"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:20:17Z","timestamp":1784290817000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,17]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2025-114092"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114092","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}